Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young… (NCT05393869) | Clinical Trial Compass
CompletedNot Applicable
Evaluating Anti-Tobacco Message Effectiveness Among Lesbian, Gay, Bisexual, and Transgender Young Adults
United States2,849 participantsStarted 2021-04-14
Plain-language summary
This trial refines and evaluates anti-tobacco messages among lesbian, gay, bisexual, and transgender (LGBT) young adults at risk for the use of more than one tobacco product (polytobacco use). Polytobacco use is associated with nicotine dependence and tobacco use into adulthood, and is disproportionately high among LGBT young adults. This trial seeks to determine effective communication of polytobacco use risk to at-risk LGBT young adults.
Who can participate
Age range
18 Years – 35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Young adults (age 18-35 years)
* Live in the United States
At least 50% of the sample also:
* Are susceptible to multiple nicotine and tobacco product use (i.e., have used combustible tobacco or e-cigarettes at least once)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study tested anti-tobacco messages specifically aimed at LGBT young adults — are there any findings from this research that might be relevant to how my own tobacco or e-cigarette use affects my cancer risk?
2The trial measured whether anti-tobacco messages changed people's intentions to use tobacco products, including e-cigarettes — does the evidence suggest that e-cigarettes are actually safer than regular cigarettes for someone in my situation, or is the risk still significant?
3Since this study is already completed, have any results been published that my care team could review to help me understand how tobacco and e-cigarette use might specifically affect my treatment outcomes or overall health?
4This trial focused on risk perception around cigarette versus e-cigarette use — based on what was learned, should I be treating e-cigarettes as equally harmful to traditional cigarettes when thinking about my tobacco use and cancer risk?
5Given that this was a message-effectiveness study rather than a treatment trial, are there evidence-based tobacco cessation programs my doctor could recommend that are specifically designed for or sensitive to LGBT patients like me?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.